6 e-Letters

published between 2014 and 2017

  • Trust IT lags behind smartphone capability
    Andrew J Clarkin

    This survey demonstrated that a significant proportion of clinicians use smartphones to share clinical information. While this rightly raises concerns over confidentiality and makes headlines in the press it is important to question why this situation has arisen. As Mobasheri and colleagues demonstrated, ownership is near ubiquitous among medical staff and this affords availability and immediacy of access. It is hardly...

    Show More
  • Response to the letter by Dr. Chiong and Prof. Attia
    Johanna Callhoff

    Thank you for your interest in our work. Your letter allows us to further explain aspects that could possibly be misunderstood. We stressed in the title and in the conclusion that depression was a predictor of the "risk to consider applying for work disability pension". The key messages could, however, be interpreted differently.

    Firstly, we decided to use a composite endpoint of obtaining work disability pens...

    Show More
  • Caveats in interpretation of the article: Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy
    Fabian Chiong

    Dear Editor,

    We read with interest the article by Johanna Callhoff and colleagues regarding depression being a stronger predictor of the risk of work disability in early arthritis than disease activity or response to therapy. On reviewing the article, we thought it is important to highlight 3 caveats in interpretation of this article.

    Firstly, the outcome was not just those who had applied for or obtained...

    Show More
  • The effectiveness of Mobile Health Technologies and Their Potential Limitations
    Atif A Baig

    After reading the entire review, I would agree with the authors and I feel there must be areas and specialities to defined and considered where this system can be used. For example, using it for pharmacy practice in few places will bring in a high potential of false prognosis as per lesser knowledge of individuals.

    I would suggest a more wider studies with a summarised meta-analysis, where the use of this system...

    Show More
  • Re:A strong clinical need may still prevent innovation
    Paul G Yock

    Dr. Sharma: You've hit upon multiple issues that certainly complicate the innovation process. Subjectivity, bias, conflicting interests, and stakeholder resistance can all prevent worthwhile needs from being addressed and valuable solutions from reaching the market. Our hope is that by taking a systematic approach to medtech invention, innovators will at least be able to anticipate these potential roadblocks and more...

    Show More
  • A strong clinical need may still prevent innovation
    Neel Sharma
    Having recently completed the Singapore Stanford Biodesign programme, I found your piece particularly timely Paul. I would fully agree that the selection of an appropriate need is paramount with regards to the innovation process. If the disease in question is not a marketable burden, in terms of morbidity and mortality so to speak, then a need in this regard is not likely to attract potential investment from a stakeholder perspect...
    Show More